Newsmeme!
Discover News you didn't know existed
Parenteral
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
USPTO awards NexBio patent covering sialidase pharmaceutical compositions and methods of treating influenza
Published February 9, 2010, 2:01 am, News-Medical-Net
NexBio, Inc. today announced the issuance by the United States Patent and Trademark Office of United States Patent No. 7,645,448 entitled "Class of Therapeutic Protein Based Molecules". This patent covers NexBio's sialidase pharmaceutical compositions, including its lead compound DAS181 (Fludase®), and methods of treating or preventing viral infection by influenza and parainfluenza with such ...
Nestle HealthCare Nutrition and HealthCare Professionals Join Forces to Improve Patient Safety
Published February 8, 2010, 12:09 pm, redOrbit
'Be A.W.A.R.E.' Initiative Drives Awareness for Improving the Safety of Enteral Medication Delivery FLORHAM PARK, N.J., Feb.
NexBio Granted United States Patent Covering DAS181 (Fludase(R) *) and its Use for Prevention and Treatment of ...
Published February 8, 2010, 12:08 pm, redOrbit
SAN DIEGO, Calif., Feb. 8 /PRNewswire/ -- NexBio, Inc. today announced the issuance by the United States Patent and Trademark Office of United States Patent No. 7,645,448 entitled "Class of Therapeutic Protein Based Molecules".
Nestle HealthCare Nutrition and HealthCare Professionals Join Forces to Improve Patient Safety
Published February 8, 2010, 8:39 am, PR Newswire via Yahoo! News
'Be A.W.A.R.E.' Initiative Drives Awareness for Improving the Safety of Enteral Medication Delivery
NexBio Granted United States Patent Covering DAS181 (Fludase(R) *) and its Use for Prevention and Treatment of ...
Published February 8, 2010, 8:00 am, PR Newswire via Yahoo! Finance
NexBio, Inc. today announced the issuance by the United States Patent and Trademark Office of United States Patent No. 7,645,448 entitled "Class of Therapeutic Protein Based Molecules". Â This patent covers NexBio's sialidase pharmaceutical compositions, including its lead compound DAS181 , and methods of treating or preventing viral infection by influenza and parainfluenza with such compositions.
Press Release
Published February 8, 2010, 3:10 am, PharmiWeb
AMAG Pharmaceuticals Inc. Posted on:06 Feb 10 AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today provided a safety update on Feraheme® (ferumoxytol) Injection for intravenous use.
AMAG Pharmaceuticals releases safety update on Feraheme Injection
Published February 5, 2010, 10:16 pm, News-Medical-Net
AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today provided a safety update on Feraheme® (ferumoxytol) Injection for intravenous use.
AMAG Pharmaceuticals Provides Feraheme® Safety Update
Published February 5, 2010, 1:17 pm, Business Wire via Yahoo! Finance
LEXINGTON, Mass.----AMAG Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today provided a safety update on Feraheme® Injection for intravenous use.
IATA Chapter 17 Revised Regulations and Biopharma Requirements for Temperature-Sensitive Products Discussion
Published February 3, 2010, 8:02 am, Business Wire via Yahoo! Finance
TORONTO----Pharma IQ, a division of IQPC, announces that Kevin O’Donnell Director & CTA of Tegrant Corporation and Chair of IATA’s Time & Temperature Task Force will discuss compliance with IATA’s revised Chapter 17 at the 8th Cold Chain Management and Temperature Control Summit.
Nutrition Services, Prevention Important In Nutrition Care For Special Health Needs
Published February 3, 2010, 3:31 am, Medical News Today
The American Dietetic Association has published an updated position paper that addresses the nutrition aspects of health care for people with developmental disabilities and special health care needs. It emphasizes prevention, coordination of care, the increasing role of technology and the importance of services provided by registered dietitians and dietetic technicians, registered...
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |